SS
OGEN icon

SBI Securities’s Oragenics OGEN Stock Holding History

SBI Securities’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6 Buy
11
+1
+10% +$1 ﹤0.01% 3902
2025
Q4 		$8 Hold
10
– – ﹤0.01% 3895
2025
Q3 		$13 Hold
10
– – ﹤0.01% 3992
2025
Q2 		$38 Buy
10
+9
+900% +$46 ﹤0.01% 3781
2025
Q1 		$6 Hold
1
– – ﹤0.01% 4018
2024
Q4 		$11 Buy
+1
New +$10 ﹤0.01% 3924

Other funds holding OGEN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
AAS
Ameritas Advisory Services Lincoln, Nebraska $2.58B AUM 18.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SJIM
St. Johns Investment Management Jacksonville, Florida $238M AUM 22.04% 1-Year Est. Return

SBI Securities's OGEN Position: Q1 2026 in Review

SBI Securities increased its Oragenics (OGEN) stake by 10% in Q1 2026, buying an estimated $1 and bringing the position to 11 shares worth $6. The position accounts for ﹤0.01% of the portfolio, ranked #3902.

SBI Securities first reported a position in OGEN in Q4 2024 and has held it in 6 quarters since. The position peaked at $38 in Q2 2025. 19 funds tracked by Wall St. Rank hold OGEN as of Q1 2026.

  • SBI Securities held 11 shares of Oragenics worth $6 as of Q1 2026.
  • SBI Securities bought 1 Oragenics share in Q1 2026, an estimated $1.
  • Oragenics made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #3902 holding.
  • SBI Securities first reported a position in Oragenics in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's Oragenics position peaked at $38 in Q2 2025.
  • 19 funds tracked by Wall St. Rank held Oragenics as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.